SE439305B - Forfarande for framstellning av 5-halogenpyrimid-2-oner, vilka er metafasinhibitorer - Google Patents

Forfarande for framstellning av 5-halogenpyrimid-2-oner, vilka er metafasinhibitorer

Info

Publication number
SE439305B
SE439305B SE7611493A SE7611493A SE439305B SE 439305 B SE439305 B SE 439305B SE 7611493 A SE7611493 A SE 7611493A SE 7611493 A SE7611493 A SE 7611493A SE 439305 B SE439305 B SE 439305B
Authority
SE
Sweden
Prior art keywords
halogenypyrimid
ones
procedure
preparation
metaphase
Prior art date
Application number
SE7611493A
Other languages
English (en)
Swedish (sv)
Other versions
SE7611493L (sv
Inventor
K Undheim
S G M Laland
M J Gacek
R Oftebro
Original Assignee
Nyegaard & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard & Co As filed Critical Nyegaard & Co As
Publication of SE7611493L publication Critical patent/SE7611493L/xx
Publication of SE439305B publication Critical patent/SE439305B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7611493A 1975-10-16 1976-10-15 Forfarande for framstellning av 5-halogenpyrimid-2-oner, vilka er metafasinhibitorer SE439305B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB42509/75A GB1561290A (en) 1975-10-16 1975-10-16 Pyrimid - 2 - ones

Publications (2)

Publication Number Publication Date
SE7611493L SE7611493L (sv) 1977-04-17
SE439305B true SE439305B (sv) 1985-06-10

Family

ID=10424751

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7611493A SE439305B (sv) 1975-10-16 1976-10-15 Forfarande for framstellning av 5-halogenpyrimid-2-oner, vilka er metafasinhibitorer

Country Status (14)

Country Link
US (1) US4395406A (enExample)
JP (1) JPS5253869A (enExample)
BE (1) BE847234A (enExample)
CA (1) CA1086736A (enExample)
CH (3) CH634308A5 (enExample)
DE (1) DE2646676A1 (enExample)
DK (1) DK144525C (enExample)
FR (1) FR2327765A1 (enExample)
GB (1) GB1561290A (enExample)
IE (1) IE44431B1 (enExample)
LU (1) LU75994A1 (enExample)
NL (1) NL7611415A (enExample)
NO (1) NO151040C (enExample)
SE (1) SE439305B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
ES498337A0 (es) * 1980-01-07 1982-06-01 Nyegaard & Co As Un procedimiento para la preparacion de 5-halo-pirimidin-2- onas
AU549117B2 (en) 1980-01-10 1986-01-16 Nyegaard & Co. A/S Pyrimidine-2-sulphides and their 5-oxides
CA1160226A (en) * 1980-07-15 1984-01-10 Gordon H. Phillipps Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, pharmaceutical compositions containing them and a method therefor
NZ197715A (en) * 1980-07-15 1984-12-14 Glaxo Group Ltd Substituted pyrimin-2-ones and pharmaceutical compositions
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
US4596870A (en) * 1981-01-09 1986-06-24 Nyegaard & Co. A.S. Substituted pyrimidin-2-ones and the salts thereof
ZA826660B (en) * 1981-09-11 1983-08-31 Nyegaard & Co As Substituted pyrimid-2-ones,the salts thereof,processes for their preparation and pharmaceutical compositions containing them
US4782142A (en) * 1982-01-05 1988-11-01 The Research Foundation Of State University Of New York Novel 5-substituted 2-pyrimidinone nucleosides and methods of use
EP0087326B1 (en) * 1982-02-24 1987-05-13 Nycomed As Substituted pyrimidin-2-ones and the salts thereof
CA1275410C (en) * 1986-03-14 1990-10-23 Karnail S. Atwal 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo) -3-substituted-2-thioxo(or oxo)-5- pyrimidinecarboxylic acids and esters
GB8706176D0 (en) * 1987-03-16 1987-04-23 Wellcome Found Therapeutic nucleosides
DE68920880D1 (de) * 1988-07-18 1995-03-09 Yamasa Shoyu Kk 1-amino-5-halogenouracile, verfahren zu deren herstellung und diese enthaltende cns-depressiva.
GB9026114D0 (en) * 1990-11-30 1991-01-16 Norsk Hydro As New compounds
AU7286696A (en) * 1995-10-13 1997-05-07 F. Hoffmann-La Roche Ag Antisense oligomers
NZ330360A (en) * 1997-06-02 1999-03-29 Hoffmann La Roche 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
EP0882734B1 (en) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5'-Deoxy-cytidine derivatives
US6005098A (en) * 1998-02-06 1999-12-21 Hoffmann-La Roche Inc. 5'deoxycytidine derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317532A (en) * 1964-11-19 1967-05-02 Hoffmann La Roche Derivatives of pyrimidine
DE2032559A1 (de) * 1970-06-27 1972-01-13 Schering Ag Berlin Und Bergkamen, 1000 Berlin N-Substituierte Amide und Lactame
US3833586A (en) * 1971-03-25 1974-09-03 Morton Norwich Products Inc 1-(substituted benzyl)-2-(1h)pyrimidones and 1-(substituted benzyl)tetrahydro-2-(1h)pyrimidones
DE2440677A1 (de) * 1974-08-24 1976-03-04 Bayer Ag Pyrimidinylthionophosphonsaeureester, verfahren zu ihrer herstellung und ihre verwendung als insektizide, akarizide und nematizide
DE2450951A1 (de) * 1974-10-26 1976-05-06 Bayer Ag Pyrimidinyl(thiono)(thiol)phosphor (phosphon)-saeureester bzw. -esteramide, verfahren zu ihrer herstellung und ihre verwendung als insektizide, akarizide und nematizide
US4003900A (en) * 1976-03-11 1977-01-18 Morton-Norwich Products, Inc. 1-Benzyl-5-chloro-2-(1H)-pyrimidone

Also Published As

Publication number Publication date
IE44431B1 (en) 1981-12-02
DE2646676A1 (de) 1977-04-28
JPS5253869A (en) 1977-04-30
GB1561290A (en) 1980-02-20
FR2327765A1 (fr) 1977-05-13
NO151040B (no) 1984-10-22
NL7611415A (nl) 1977-04-19
CH634310A5 (de) 1983-01-31
BE847234A (fr) 1977-04-13
DE2646676C2 (enExample) 1987-06-19
DK144525C (da) 1982-10-18
CH634309A5 (de) 1983-01-31
LU75994A1 (enExample) 1977-05-11
DK144525B (da) 1982-03-22
FR2327765B1 (enExample) 1981-11-20
DK462376A (da) 1977-04-17
NO151040C (no) 1985-01-30
SE7611493L (sv) 1977-04-17
NO763533L (enExample) 1977-04-19
CH634308A5 (de) 1983-01-31
CA1086736A (en) 1980-09-30
IE44431L (en) 1977-04-16
US4395406A (en) 1983-07-26

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
AR217629A1 (es) Procedimiento de preparacion de derivados de tienotetrahidropiridina
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
DK298476A (da) Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater
SE419983B (sv) Forfarande for framstellning av finkornig, fast cyanurklorid
DK137275C (da) Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE428469B (sv) Forfarande for framstellning av tertiera aminer.
IT1066001B (it) Procedimento per l esterificazione di clorosilani
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
NO142444C (no) Fremgangsmaate for fremstilling av foretrede melamin-formaldehydharpikser i vandig opploesning
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
NO143314C (no) Fremgangsmaate for fremstilling av akrylamid
DK253676A (da) Fremgangsmade til fremstilling af cycloheptathiopenderivater
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE7608589L (sv) Forfarande for framstellning av fortimicin c
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
DK141532C (da) Fremgangsmaade til fremstilling af 21-hydroxy-16-pregnen-20-onderivater

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7611493-3

Effective date: 19880627

Format of ref document f/p: F